Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes

Lim, L. Y. et al. (2015) Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes. Nanomedicine: Nanotechnology, Biology and Medicine, 11(6), pp. 1445-1454. (doi: 10.1016/j.nano.2015.04.006) (PMID:25933695) (PMCID:PMC4509555)

113079.pdf - Published Version
Available under License Creative Commons Attribution.



The possibility of using gene therapy for the treatment of cancer is limited by the lack of safe, intravenously administered delivery systems able to selectively deliver therapeutic genes to tumors. In this study, we investigated if the conjugation of the polypropylenimine dendrimer to lactoferrin and lactoferricin, whose receptors are overexpressed on cancer cells, could result in a selective gene delivery to tumors and a subsequently enhanced therapeutic efficacy. The conjugation of lactoferrin and lactoferricin to the dendrimer significantly increased the gene expression in the tumor while decreasing the non-specific gene expression in the liver. Consequently, the intravenous administration of the targeted dendriplexes encoding TNFα led to the complete suppression of 60% of A431 tumors and up to 50% of B16-F10 tumors over one month. The treatment was well tolerated by the animals. These results suggest that these novel lactoferrin- and lactoferricin-bearing dendrimers are promising gene delivery systems for cancer therapy.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Mullin, Mrs Margaret
Authors: Lim, L. Y., Koh, P. Y., Somani, S., Al Robaian, M., Karim, R., Yean, Y. L., Mitchell, J., Tate, R. J., Edrada-Ebel, R., Blatchford, D. R., Mullin, M., and Dufès, C.
College/School:College of Medical Veterinary and Life Sciences > School of Life Sciences
Journal Name:Nanomedicine: Nanotechnology, Biology and Medicine
Publisher:Elsevier Inc.
ISSN (Online):1549-9642
Copyright Holders:Copyright © 2015 The Authors
First Published:First published in Nanomedicine: Nanotechnology, Biology and Medicine 11(6):1445-1454
Publisher Policy:Reproduced under a creative commons license

University Staff: Request a correction | Enlighten Editors: Update this record